Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
2017_-_fall-term [2017/09/13 12:07] morgal |
2017_-_fall-term [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 17: | Line 17: | ||
| [[ Group 2, Presentation 2 - Epilepsy]] | [[ Group 2, Presentation 2 - Epilepsy]] | ||
| === === | === === | ||
| - | [[ Group 3, Presentation 2 - LSD's (lysergic acid diethylamide) effect on the brain]] | + | [[ Group 3, Presentation 2 - Lysergic Acid Diethylamide (LSD)]] |
| === === | === === | ||
| [[ Group 4, Presentation 2 -Aplastic Anemia ]] | [[ Group 4, Presentation 2 -Aplastic Anemia ]] | ||
| Line 27: | Line 27: | ||
| [[ Group 1, Presentation 3 - Parkinson's Disease ]] | [[ Group 1, Presentation 3 - Parkinson's Disease ]] | ||
| === === | === === | ||
| - | [[ Group 2, Presentation 3 - Addison's Disease ]] | + | [[ Group 2, Presentation 3 - Ebola ]] |
| === === | === === | ||
| - | [[ Group 3, Presentation 3 - Venom from a Brazilian Wandering Spider and its effect on our body]] | + | [[ Group 3, Presentation 3 - Snake Venom]] |
| === === | === === | ||
| [[ Group 4, Presentation 3 -Burns ]] | [[ Group 4, Presentation 3 -Burns ]] | ||
| Line 35: | Line 35: | ||
| [[ Group 5, Presentation 3 - Chronic Myeloid Leukemia]] | [[ Group 5, Presentation 3 - Chronic Myeloid Leukemia]] | ||
| === === | === === | ||
| - | {{::screen_shot_2017-09-05_at_1.47.03_pm.png?200|}} | + | {{::4M03_2017_Fall Term_List.png?200|}} |
